Pfizer Inc. ( PFE) - Key Metrics
PFE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $3.09 | -$0.29 | ? | ? |
| 2025Q3 | $2.93 | $0.62 | $0.81 | $0.70 |
| 2025Q2 | $2.58 | $0.51 | -$0.10 | -$0.21 |
| 2025Q1 | $2.42 | $0.52 | $0.41 | $0.31 |
PFE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | -148.28% | -21.47 |
| 2025Q3 | 69.02% | 9.57 |
| 2025Q2 | 84.02% | 11.84 |
| 2025Q1 | 82.14% | 12.12 |
PFE Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 1.38% | ? |
| 2025Q4 | 3.18% | 1.73% |
| 2025Q3 | 2.95% | 1.80% |
| 2025Q2 | -0.87% | 1.77% |
| 2025Q1 | 1.23% | 1.69% |
PFE
List: Contenders
Price: $24.26
Dividend Yield: 6.78%
Forward Dividend Yield: 7.20%
Payout Ratio: -365.22%
Dividend Per Share: 1.72 USD
Earnings Per Share: 1.31 USD
P/E Ratio: 19.60
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 23.8 million
Ebitda: 3.6 billionMarket Capitalization: 144.5 billion
Average Dividend Frequency: 4
Years Paying Dividends: 55
DGR3: 2.47%
DGR5: 2.81%
DGR10: 4.66%
DGR20: 5.27%